Great news to share! 🎉 Congratulations to C-Path President and COO Kristen Swingle on her appointment to the Board of the Institute for Advanced Clinical Trials for Children. This esteemed nonprofit is dedicated to driving innovation and expediting pediatric drug development — a mission that resonates deeply with C-Path's own commitment to advancing pediatric research and data sharing. We're thrilled to share in Kristen's enthusiasm as she embarks on this journey and look forward to the collaboration and shared learning that will follow. "𝘐 𝘢𝘮 𝘩𝘰𝘯𝘰𝘳𝘦𝘥 𝘵𝘰 𝘫𝘰𝘪𝘯 𝘵𝘩𝘦 𝘣𝘰𝘢𝘳𝘥 𝘰𝘧 𝘐𝘈𝘊𝘛4𝘊, 𝘢𝘯 𝘰𝘳𝘨𝘢𝘯𝘪𝘻𝘢𝘵𝘪𝘰𝘯 𝘵𝘩𝘢𝘵 𝘪𝘴 𝘢𝘵 𝘵𝘩𝘦 𝘧𝘰𝘳𝘦𝘧𝘳𝘰𝘯𝘵 𝘰𝘧 𝘥𝘳𝘪𝘷𝘪𝘯𝘨 𝘪𝘯𝘯𝘰𝘷𝘢𝘵𝘪𝘰𝘯 𝘪𝘯 𝘱𝘦𝘥𝘪𝘢𝘵𝘳𝘪𝘤 𝘥𝘳𝘶𝘨 𝘥𝘦𝘷𝘦𝘭𝘰𝘱𝘮𝘦𝘯𝘵,” 𝘒𝘳𝘪𝘴𝘵𝘦𝘯 𝘴𝘢𝘪𝘥. “𝘌𝘯𝘴𝘶𝘳𝘪𝘯𝘨 𝘵𝘩𝘢𝘵 𝘤𝘩𝘪𝘭𝘥𝘳𝘦𝘯 𝘩𝘢𝘷𝘦 𝘢𝘤𝘤𝘦𝘴𝘴 𝘵𝘰 𝘴𝘢𝘧𝘦 𝘢𝘯𝘥 𝘦𝘧𝘧𝘦𝘤𝘵𝘪𝘷𝘦 𝘵𝘳𝘦𝘢𝘵𝘮𝘦𝘯𝘵𝘴 𝘪𝘴 𝘢 𝘮𝘪𝘴𝘴𝘪𝘰𝘯 𝘵𝘩𝘢𝘵 𝘳𝘦𝘴𝘰𝘯𝘢𝘵𝘦𝘴 𝘥𝘦𝘦𝘱𝘭𝘺 𝘸𝘪𝘵𝘩 𝘮𝘦. 𝘐 𝘭𝘰𝘰𝘬 𝘧𝘰𝘳𝘸𝘢𝘳𝘥 𝘵𝘰 𝘤𝘰𝘯𝘵𝘳𝘪𝘣𝘶𝘵𝘪𝘯𝘨 𝘵𝘰 𝘐𝘈𝘊𝘛4𝘊’𝘴 𝘦𝘧𝘧𝘰𝘳𝘵𝘴 𝘵𝘰 𝘢𝘥𝘷𝘢𝘯𝘤𝘦 𝘳𝘦𝘴𝘦𝘢𝘳𝘤𝘩 𝘢𝘯𝘥 𝘪𝘮𝘱𝘳𝘰𝘷𝘦 𝘵𝘩𝘦 𝘭𝘪𝘷𝘦𝘴 𝘰𝘧 𝘤𝘩𝘪𝘭𝘥𝘳𝘦𝘯 𝘵𝘩𝘳𝘰𝘶𝘨𝘩 𝘮𝘰𝘳𝘦 𝘦𝘧𝘧𝘪𝘤𝘪𝘦𝘯𝘵 𝘢𝘯𝘥 𝘪𝘮𝘱𝘢𝘤𝘵𝘧𝘶𝘭 𝘤𝘭𝘪𝘯𝘪𝘤𝘢𝘭 𝘵𝘳𝘪𝘢𝘭𝘴." #CPath #IACT4C #clinicaltrials #pediatrics #collaboration #drugdevelopment #datasharing #globalhealth
📣 𝐈-𝐀𝐂𝐓 𝐟𝐨𝐫 𝐂𝐡𝐢𝐥𝐝𝐫𝐞𝐧 𝐀𝐧𝐧𝐨𝐮𝐧𝐜𝐞𝐬 𝐭𝐡𝐞 𝐀𝐩𝐩𝐨𝐢𝐧𝐭𝐦𝐞𝐧𝐭 𝐨𝐟 𝐓𝐰𝐨 𝐍𝐞𝐰 𝐁𝐨𝐚𝐫𝐝 𝐌𝐞𝐦𝐛𝐞𝐫𝐬 I-ACT for Children (IACT4C) is pleased to announce that two new members are joining its Board of Directors. The new board members bring years of experience and leadership to help advance our mission. The new board members include: ⚜ Stephanie Duggins Davis, MD ⚜ Kristen Swingle, MS “…𝘛𝘩𝘦 𝘦𝘹𝘱𝘦𝘳𝘵𝘪𝘴𝘦 𝘢𝘯𝘥 𝘦𝘹𝘱𝘦𝘳𝘪𝘦𝘯𝘤𝘦 𝘰𝘧 𝘰𝘶𝘳 𝘯𝘦𝘸 𝘣𝘰𝘢𝘳𝘥 𝘮𝘦𝘮𝘣𝘦𝘳𝘴 𝘸𝘪𝘭𝘭 𝘤𝘰𝘮𝘱𝘭𝘦𝘮𝘦𝘯𝘵 𝘰𝘶𝘳 𝘦𝘹𝘪𝘴𝘵𝘪𝘯𝘨 𝘭𝘦𝘢𝘥𝘦𝘳𝘴𝘩𝘪𝘱 𝘪𝘯 𝘢𝘥𝘷𝘢𝘯𝘤𝘪𝘯𝘨 𝘰𝘶𝘳 𝘮𝘪𝘴𝘴𝘪𝘰𝘯…” 𝘴𝘢𝘪𝘥 𝘓𝘢𝘶𝘳𝘢 𝘓𝘰𝘱𝘦𝘻, 𝘊𝘍𝘈𝘖 𝘰𝘧 𝘐𝘈𝘊𝘛4𝘊. 𝐒𝐭𝐞𝐩𝐡𝐚𝐧𝐢𝐞 𝐃𝐮𝐠𝐠𝐢𝐧𝐬 𝐃𝐚𝐯𝐢𝐬 Stephanie Duggins Davis, MD is the Edward C. Curnen, Jr. Distinguished Professor and Chair for the Department of Pediatrics of University of North Carolina at Chapel Hill and the Physician-in-Chief UNC Children’s. She has served in several high-profile national leadership roles, including President of the Society of Pediatric Research, Chair of the Board of Directors for the American Board of Pediatrics, and Chair of the Pediatric Assembly for the American Thoracic Society. “𝘛𝘩𝘦 𝘮𝘪𝘴𝘴𝘪𝘰𝘯 𝘰𝘧 𝘐-𝘈𝘊𝘛 𝘵𝘰 𝘢𝘤𝘤𝘦𝘭𝘦𝘳𝘢𝘵𝘦 𝘥𝘳𝘶𝘨 𝘥𝘦𝘷𝘦𝘭𝘰𝘱𝘮𝘦𝘯𝘵 𝘢𝘯𝘥 𝘳𝘦𝘥𝘶𝘤𝘦 𝘵𝘩𝘦 𝘸𝘢𝘪𝘵 𝘸𝘪𝘭𝘭 𝘵𝘳𝘢𝘯𝘴𝘧𝘰𝘳𝘮 𝘵𝘩𝘦 𝘤𝘢𝘳𝘦 𝘰𝘧 𝘤𝘩𝘪𝘭𝘥𝘳𝘦𝘯. 𝘐 𝘢𝘮 𝘵𝘳𝘶𝘭𝘺 𝘩𝘰𝘯𝘰𝘳𝘦𝘥 𝘵𝘰 𝘫𝘰𝘪𝘯 𝘵𝘩𝘦 𝘐-𝘈𝘊𝘛 𝘉𝘰𝘢𝘳𝘥 𝘰𝘧 𝘋𝘪𝘳𝘦𝘤𝘵𝘰𝘳𝘴 𝘢𝘯𝘥 𝘱𝘳𝘰𝘮𝘰𝘵𝘦 𝘵𝘩𝘪𝘴 𝘷𝘪𝘴𝘪𝘰𝘯.” Kristen Swingle Kristen Swingle,MS is the President and Chief Operating Officer of the Critical Path Institute (C-Path), bringing over 20 years of expertise in the medical and molecular sciences industry. With a robust background in product development, manufacturing, quality and regulatory affairs, and project and fiscal management, Kristen is a proven leader in driving innovation and operational excellence. In her role at C-Path, she oversees the organization’s daily operations, while spearheading the development and execution of its global strategy and objectives. "𝘐 𝘢𝘮 𝘩𝘰𝘯𝘰𝘳𝘦𝘥 𝘵𝘰 𝘫𝘰𝘪𝘯 𝘵𝘩𝘦 𝘣𝘰𝘢𝘳𝘥 𝘰𝘧 𝘐𝘈𝘊𝘛4𝘊, 𝘢𝘯 𝘰𝘳𝘨𝘢𝘯𝘪𝘻𝘢𝘵𝘪𝘰𝘯 𝘵𝘩𝘢𝘵 𝘪𝘴 𝘢𝘵 𝘵𝘩𝘦 𝘧𝘰𝘳𝘦𝘧𝘳𝘰𝘯𝘵 𝘰𝘧 𝘥𝘳𝘪𝘷𝘪𝘯𝘨 𝘪𝘯𝘯𝘰𝘷𝘢𝘵𝘪𝘰𝘯 𝘪𝘯 𝘱𝘦𝘥𝘪𝘢𝘵𝘳𝘪𝘤 𝘥𝘳𝘶𝘨 𝘥𝘦𝘷𝘦𝘭𝘰𝘱𝘮𝘦𝘯𝘵,” 𝘒𝘳𝘪𝘴𝘵𝘦𝘯 𝘴𝘢𝘪𝘥. “𝘌𝘯𝘴𝘶𝘳𝘪𝘯𝘨 𝘵𝘩𝘢𝘵 𝘤𝘩𝘪𝘭𝘥𝘳𝘦𝘯 𝘩𝘢𝘷𝘦 𝘢𝘤𝘤𝘦𝘴𝘴 𝘵𝘰 𝘴𝘢𝘧𝘦 𝘢𝘯𝘥 𝘦𝘧𝘧𝘦𝘤𝘵𝘪𝘷𝘦 𝘵𝘳𝘦𝘢𝘵𝘮𝘦𝘯𝘵𝘴 𝘪𝘴 𝘢 𝘮𝘪𝘴𝘴𝘪𝘰𝘯 𝘵𝘩𝘢𝘵 𝘳𝘦𝘴𝘰𝘯𝘢𝘵𝘦𝘴 𝘥𝘦𝘦𝘱𝘭𝘺 𝘸𝘪𝘵𝘩 𝘮𝘦. 𝘐 𝘭𝘰𝘰𝘬 𝘧𝘰𝘳𝘸𝘢𝘳𝘥 𝘵𝘰 𝘤𝘰𝘯𝘵𝘳𝘪𝘣𝘶𝘵𝘪𝘯𝘨 𝘵𝘰 𝘐𝘈𝘊𝘛4𝘊’𝘴 𝘦𝘧𝘧𝘰𝘳𝘵𝘴 𝘵𝘰 𝘢𝘥𝘷𝘢𝘯𝘤𝘦 𝘳𝘦𝘴𝘦𝘢𝘳𝘤𝘩 𝘢𝘯𝘥 𝘪𝘮𝘱𝘳𝘰𝘷𝘦 𝘵𝘩𝘦 𝘭𝘪𝘷𝘦𝘴 𝘰𝘧 𝘤𝘩𝘪𝘭𝘥𝘳𝘦𝘯 𝘵𝘩𝘳𝘰𝘶𝘨𝘩 𝘮𝘰𝘳𝘦 𝘦𝘧𝘧𝘪𝘤𝘪𝘦𝘯𝘵 𝘢𝘯𝘥 𝘪𝘮𝘱𝘢𝘤𝘵𝘧𝘶𝘭 𝘤𝘭𝘪𝘯𝘪𝘤𝘢𝘭 𝘵𝘳𝘪𝘢𝘭𝘴." Go to www.iactc.org to learn more about IACT4C. #IACT4C